GenVec, Inc. (NASDAQ:GNVC) shares ended at $ 6.57 with 1.67 mln shares exchanging hands. That puts the market capitalization at $ 14.72 mln. It opened the session with a $ 6.12 price tag, later ranging from $ 6.11 to $ 7.14, the range at which the stock has traded at throughout the day. The stock stands nearly -53.07% off versus the 52-week high and 143.33% away from the 52-week low. The number of shares currently owned by investors are 2.24 mln.
Sell-side analyst recommendations point to a short term price target of $ 15 on the shares of GenVec, Inc. (GNVC). The consensus rating is 2, indicating analysts in general look favorably on the company’s future prospects. It has been assigned a low target price of $ 15 and a high target price of $ 15.
The current price is staying above the SMA lines which signify strength and is generally healthy/positive and may provide the momentum for driving the share price higher. Current price places the company’s stock 22.9% away from its 200-day simple moving average, 70.53%, away from the 50-day average and also 42.64% away from 20-day average.
For this year, GenVec, Inc. (NASDAQ:GNVC) is performing 104.67%. Over the past five trading sessions it is 7.18%; 107.26% for the month; 72.89% for the last quarter; 11.36% for the past six-months; and 31.4% for the last 12 months. The last close places the company’s stock about $ 3.87 off its 52 week high of $ 10.44 and $ 6.3 above the 52 week low of $ 0.27.
Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) closed up +0.02 points or 4.93% at $ 0.31 with 1.67 mln shares exchanging hands. Current price level places the company’s stock about -72.66% from the 52-week high and 9.36% away from the 52-week low. The consensus rating is 1.5, indicating analysts in general look favorably on the company’s future prospects.
Peregrine Pharmaceuticals, Inc. (PPHM) opened the session with a $ 0.292 price tag, later ranging from $ 0.2857 to $ 0.31, the range at which the stock has traded at throughout the day. The stock stands nearly $ 0.83 off versus the 52-week high of $ 1.12 and $ 0.01 above the 52-week low of $ 0.28. The number of shares currently owned by investors are 259.03 mln. The current price change puts the market capitalization at $ 79.31 mln.
Over the past five trading sessions shares of Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) are 5.59%; -1.23% for the month; -9.94% for the last quarter; -17.24% for the past six-months; and -70.27% for the last 12 months. The current price is staying above the SMA lines which signify strength and is generally healthy/positive and may provide the momentum for driving the share price higher. Current price places the company’s stock -16.4% away from its 200-day simple moving average, -1.92%, away from the 50-day average and also 0.4% away from 20-day average. The stock is performing -1.23% year to date.
Healthcare Shares Need To Consider: GenVec, Inc. (NASDAQ:GNVC), Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM)